S. Engel

585 total citations
29 papers, 398 citations indexed

About

S. Engel is a scholar working on General Health Professions, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S. Engel has authored 29 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in General Health Professions, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S. Engel's work include Health and Medical Studies (7 papers), Heart Failure Treatment and Management (5 papers) and Dementia and Cognitive Impairment Research (4 papers). S. Engel is often cited by papers focused on Health and Medical Studies (7 papers), Heart Failure Treatment and Management (5 papers) and Dementia and Cognitive Impairment Research (4 papers). S. Engel collaborates with scholars based in Germany, Switzerland and United States. S. Engel's co-authors include Hannelore Löwel, Ulrich Keil, A. Hörmann, Wolfgang Köenig, Elmar Graessel, Anna Pendergrass, Roland Linder, Frank Verheyen, Stephan Holmer and Christian Hengstenberg and has published in prestigious journals such as Diabetologia, American Heart Journal and Journal of Internal Medicine.

In The Last Decade

S. Engel

27 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Engel Germany 11 127 78 66 60 53 29 398
Justin Houman United States 12 55 0.4× 86 1.1× 53 0.8× 143 2.4× 57 1.1× 28 470
Dominic Tilden Australia 12 66 0.5× 45 0.6× 26 0.4× 50 0.8× 30 0.6× 37 476
Sandra M. Dumanski Canada 12 92 0.7× 37 0.5× 63 1.0× 72 1.2× 152 2.9× 37 488
S. Davies United Kingdom 11 54 0.4× 43 0.6× 42 0.6× 25 0.4× 31 0.6× 17 435
George Dantas Azevedo Brazil 16 166 1.3× 71 0.9× 83 1.3× 72 1.2× 236 4.5× 46 725
Theresa Coles United States 11 32 0.3× 67 0.9× 43 0.7× 67 1.1× 41 0.8× 52 379
Sandra van Dijk Netherlands 15 63 0.5× 128 1.6× 31 0.5× 43 0.7× 166 3.1× 42 686
Stacy Christiansen United States 6 50 0.4× 60 0.8× 32 0.5× 26 0.4× 66 1.2× 23 349
Christopher M. Deibert United States 14 36 0.3× 166 2.1× 45 0.7× 300 5.0× 120 2.3× 58 791
AlJohara M AlQuaiz Saudi Arabia 13 36 0.3× 99 1.3× 35 0.5× 34 0.6× 111 2.1× 26 503

Countries citing papers authored by S. Engel

Since Specialization
Citations

This map shows the geographic impact of S. Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Engel more than expected).

Fields of papers citing papers by S. Engel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Engel. The network helps show where S. Engel may publish in the future.

Co-authorship network of co-authors of S. Engel

This figure shows the co-authorship network connecting the top 25 collaborators of S. Engel. A scholar is included among the top collaborators of S. Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Engel. S. Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bethel, M. Angelyn, S. Engel, Eberhard Standl, et al.. (2016). Assessing the safety of sitagliptin in elderly participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Diabetic Medicine. 33. 86–86. 1 indexed citations
3.
Engel, S., et al.. (2016). „EduKation demenz®“. Zeitschrift für Gerontologie und Geriatrie. 49(3). 187–195. 6 indexed citations
4.
Neubauer, Stefan, Tobias Schilling, Jan Zeidler, et al.. (2016). Auswirkung einer leitliniengerechten Behandlung auf die Mortalität bei Linksherzinsuffizienz. Herz. 41(7). 614–624. 9 indexed citations
5.
Neubauer, Stefan, Jan Zeidler, Tobias Schilling, et al.. (2016). Eignung und Anwendung von GKV-Routinedaten zur Überprüfung von Versorgungsleitlinien am Beispiel der Indikation Linksherzinsuffizienz. Das Gesundheitswesen. 78(S 01). e135–e144. 4 indexed citations
6.
Neubauer, Stefan, Jan Zeidler, Tobias Schilling, et al.. (2016). Eignung und Anwendung von GKV-Routinedaten zur Überprüfung von Versorgungsleitlinien am Beispiel der Indikation Linksherzinsuffizienz Suitability and Usability of Claims Data for Review of Guidelines for the Treatment of Chronic Heart Failure. 1 indexed citations
7.
Schaller, Sandra, Manfred Criegee‐Rieck, Lena Griebel, et al.. (2015). Tailored e-Health services for the dementia care setting: a pilot study of ‘eHealthMonitor’. BMC Medical Informatics and Decision Making. 15(1). 58–58. 34 indexed citations
8.
Bowles, David S., Radoslaw Wasiak, Floortje van Nooten, et al.. (2014). Economic burden of neural tube defects in Germany. Public Health. 128(3). 274–281. 14 indexed citations
9.
Horenkamp‐Sonntag, Dirk, et al.. (2014). Validität von GKV-Routinedaten: In welchem Umfang muss bei der wissenschaftlichen Nutzung von Sekundärdaten die Daten-Qualität geprüft werden?. Zeitschrift für Palliativmedizin. 15(3). 1 indexed citations
10.
McLennan, Stuart, et al.. (2013). Implementation status of error disclosure standards reported by Swiss hospitals. Swiss Medical Weekly. 143(2728). w13820–w13820. 8 indexed citations
11.
Linder, Roland, et al.. (2013). 10 Jahre Diabetes-DMP - Ein medizinischer oder ökonomischer Nutzen ist nicht erkennbar. 11(3). 124–126. 1 indexed citations
12.
Zeidler, Jan, Ansgar Lange, S. Braun, et al.. (2013). Die Berechnung indikationsspezifischer Kosten bei GKV-Routinedatenanalysen am Beispiel von ADHS. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 56(3). 430–438. 5 indexed citations
13.
Kamphues, Carsten, S. Engel, Timm Denecke, et al.. (2011). Safety of liver resection and effect on quality of life in patients with benign hepatic disease: Single center experience. BMC Surgery. 11(1). 16–16. 19 indexed citations
14.
Kamphues, Carsten, et al.. (2011). Laparoscopic fenestration of non-parasitic liver cysts and health-related quality of life assessment. Updates in Surgery. 63(4). 243–247. 14 indexed citations
15.
Renner, Stefan P., Reiner Strick, Peter Oppelt, et al.. (2005). Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis. Reproduction. 131(1). 153–161. 34 indexed citations
16.
Engel, S., et al.. (2003). Gedächtniszentrum Erlangen - eine teilstationäre gerontopsychiatrische Einrichtung. PubMed. 30(Suppl 2). 207–211.
17.
Metzger, Marie-Hélène, S. Engel, Christian Hengstenberg, et al.. (2002). Do siblings of myocardial infarction patients have a specific management of hypertension?. Journal of Human Hypertension. 16(1). 67–74. 1 indexed citations
18.
Holmer, Stephan, Christian Hengstenberg, Bernd Mayer, et al.. (2001). Marked suppression of renin levels by β‐receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from β‐blockade. Journal of Internal Medicine. 249(2). 167–172. 35 indexed citations
19.
Löwel, Hannelore, Wolfgang Köenig, S. Engel, A. Hörmann, & Ulrich Keil. (2000). The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment?. Diabetologia. 43(2). 218–226. 84 indexed citations
20.
Luchner, Andreas, Christian Hengstenberg, Hannelore Löwel, et al.. (2000). Evaluation of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) as Marker of Impaired Left Ventricular Function After Myocardial Infarction. European Journal of Heart Failure. 2(S1). 47–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin Houman Breakdown of academic impact, for papers by Dominic Tilden Breakdown of academic impact, for papers by Sandra M. Dumanski Breakdown of academic impact, for papers by S. Davies Breakdown of academic impact, for papers by George Dantas Azevedo Breakdown of academic impact, for papers by Theresa Coles Breakdown of academic impact, for papers by Sandra van Dijk Breakdown of academic impact, for papers by Stacy Christiansen Breakdown of academic impact, for papers by Christopher M. Deibert Breakdown of academic impact, for papers by AlJohara M AlQuaiz
Rankless by CCL
2026